Tamil Nadu Newsprint and Papers Ltd, the leading manufacturer of printing and writing papers and newsprint in India, has plans to spend Rs 1000 crore on capacity expansion.

Through the latest decision, the company intends to tap 12-13% market share of the printing and writing paper segment, by 2011-12.

Mumbai-headquartered Aptech Ltd, has entered into a 51:49 joint venture with Falgo group to set up various IT training centers in Brazil.

Under the arrangement, the company will setup its first centre in Brazil up by August.

Latest reports suggest that, investment in the Brazilian venture is pegged at $1 million. However, the final disclosure from the companies has yet to come.

The company said, all courses, which it offered in Brazil would be in line with the Brazilian university programmes.

Medical technology products manufacturer Trivitron Group of Companies, has formed an alliance with BioSystems, Spain, to manufacture in-vitro diagnostic (IVD) reagents.

It should be noted that this is the third manufacturing joint venture for Trivitron in recent times. Earlier, the firm has signed joint ventures with Brandon Medical for making operation theatre bulbs and Aloka of Japan for portable ultrasound scanners.

Property developer Indiabulls Real Estate (IBREL) has informed that company's board of directors has finally approved a plan to raise $600 million (Rs 3,000 crore) through qualified institutional placement (QIP) of securities.

The QIP proceeds are expected to be utilized for funding its power projects, mainly a 1,320-megawatt project planned in Amaravati in Maharashtra.

The board of directors took a decision to this effect at its meeting on April 24 (Friday).

Covidien, a $10 billion global healthcare products leader, has announced its entry into the Indian healthcare market with the establishment of its headquarters at Gurgaon.

The company intends to collaborate with the region's healthcare providers to offer its cutting-edge medical solutions and services throughout the country.

According to sources, Covidien will setup three 'dry labs' this year to initiate training programmes for medical practitioners in the country. In addition, it will also introduce some of its patented products in India.

Shantha Biotechnics, a pioneer in the biotechnology field, has made announcement about the launching of its bivalent oral cholera vaccine, 'Shanchol'.

Shanchol, which is believed to the first of its kind in the world, will be launched on Sunday during a two-day seminar on Continuous Medical Education (CME) of National Infectious Diseases organized by Indian Academy of Pediatrics at Kolkata.